Advertisement
 
YOU ARE HERE: LAT HomeCollectionsHormones
IN THE NEWS

Hormones

NEWS
December 28, 1990 | NYU SCHOOL OF MEDICINE, Associated Press Newsfeatures
Research suggests that treatment with human growth hormone may reverse some of the effects that aging has on the body. Injecting a genetically engineered version of the natural body hormone led to an increase in muscle mass and a decrease in body fat in a group of men ranging in age from 61 to 81 years old. However, the results are preliminary, and the long-term effects of human growth hormone have yet to be determined.
Advertisement
BUSINESS
August 21, 2008 | From Times Wire Services
Drug maker Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement will expand Lilly's veterinary operations and enable St. Louis-based Monsanto to focus on genetically modified crops. Lilly, based in Indianapolis, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Ga. It also inherits opposition to the hormone from consumer advocates and some dairy processors.
HEALTH
April 9, 2007 | From Times wire reports
Scientists call it the love hormone, the chemical that binds people to one another. Now researchers from the University of Zurich in Switzerland have found that the hormone, released in high amounts in mothers after childbirth, can improve a person's ability to interpret what is going on in another person -- by reading information gleaned from their eyes.
CALIFORNIA | LOCAL
July 4, 1988 | From Times Staff and Wire Reports
Smoking gives post-menopausal women higher levels of two male hormones, suggesting that the hormones might account for the higher incidence of heart attacks among women smokers, researchers at UC San Diego say. The findings also point to hormones as the potential explanation for why men are three times more likely than women to have cardiovascular disease.
NEWS
August 4, 1989 | JANNY SCOTT, Times Medical Writer
The startling finding that a popular hormone therapy used to treat menopause and prevent osteoporosis may promote breast cancer left many women wondering this week whether they should reconsider taking so-called replacement hormones. The finding, announced Tuesday in Sweden, emerged from a study of women over age 34 who took hormones for at least six years. While estrogen alone had a slight impact on their risk of breast cancer, estrogen and progestin together raised it fourfold.
HEALTH
May 31, 2010 | By Jill U Adams, Special to the Los Angeles Times
In women, postpartum depression is well-known, long-studied and blamed in large part on biological factors. After all, pregnancy-related hormone levels plummet after the baby's birth, leaving many new moms weepy on the very day they arrive home from the hospital. From there on out, recovery from labor, bodily changes and nursing (or not) can contribute to, if not trigger, both the milder baby blues and outright clinical depression. But new fathers suffer from pre- and postpartum depression as well, researchers have learned.
CALIFORNIA | LOCAL
September 19, 1988
Some binge eaters produce unusually small amounts of a hormone that ordinarily signals people that they are full, according to a study. The report suggests that a defect in production of this natural chemical may be an underlying cause of bulimia nervosa, an eating disorder in which people stuff themselves with food and then make themselves vomit. The study compared 14 women with bulimia to 10 healthy volunteers.
NEWS
July 24, 2001 | ROSIE MESTEL, TIMES MEDICAL WRITER
Hormone replacement therapy should not be given to women solely for the purpose of preventing heart disease because the benefits are ambiguous at best, the American Heart Assn. recommended today. The suggestion from the nation's leading group of heart doctors adds another twist to the complex calculations faced by many of the 50 million American women over age 50 as they ponder whether to use hormone therapy.
NEWS
July 2, 1990 | THOMAS H. MAUGH II, TIMES SCIENCE WRITER
A new strain of midget mice that are only half normal size has been developed by Ohio University researchers who accomplished the feat by modifying the gene for a growth hormone and inserting it into the animals, the scientists report today. The researchers say the technique should work for any animal, so it should be possible to develop small rodents, pigs and other laboratory animals that would require less space and food.
Los Angeles Times Articles
|